Pediatric Medication Dosing: Weight-Based Calculation with Age-Based Estimation
Calculate pediatric medication doses using weight-based formulas (mg/kg) whenever the child's actual weight is available; when weight is unavailable, use age-based estimation formulas as a backup, recognizing that modern children weigh more than historical averages. 1, 2
Primary Approach: Weight-Based Dosing
Always use the child's actual measured weight in kilograms to calculate the dose using the medication's specific mg/kg recommendation from the prescribing information. 1, 2, 3, 4
Key Weight-Based Principles:
Dose per weight is based on ideal body weight—children weighing more than 40 kg should typically be dosed as adults. 1, 5
For children under 2 years, hydrophilic drugs with high volume of distribution should be normalized to body weight, while those with low volume of distribution should be normalized to body surface area (BSA). 6
After 6 months of age, BSA becomes a reliable marker for most drug dosing, though drugs metabolized by CYP2D6 and UGT should still be normalized to body weight. 6
In the first 2 years of life, drugs with significant renal excretion require dose adjustment based on renal function markers (serum creatinine, creatinine clearance). 6
Practical Weight-Based Examples:
Oseltamivir (influenza treatment): Children ≤15 kg receive 30 mg twice daily; >15–23 kg receive 45 mg twice daily; >23–40 kg receive 60 mg twice daily; >40 kg receive 75 mg twice daily. 2, 3, 4, 2
Amantadine: 5 mg/kg/day (not to exceed 150 mg/day) for children 1–9 years; children <40 kg receive 5 mg/kg/day regardless of age. 2, 7
Paracetamol: 10–15 mg/kg every 4–6 hours, not exceeding 75 mg/kg/day or 4 g/day (whichever is lower). 8
Ondansetron: 0.15 mg/kg IV/IM (maximum 16 mg per dose), repeated every 8 hours as needed. 9
Secondary Approach: Age-Based Estimation When Weight Is Unavailable
When actual weight cannot be obtained in emergency or urgent situations, use modern age-based estimation formulas that account for increased average weights in contemporary children. 10, 11
Updated Age-Based Weight Estimation Formulas:
The traditional APLS formula (Weight = 2[age + 4]) significantly underestimates modern children's weights by 33.4% and should be avoided. 11
Recommended Modern Formula (More Accurate):
Infants <12 months: Weight (kg) = (age in months + 9) ÷ 2 10
Children 1–5 years: Weight (kg) = 2 × (age in years + 5) 10
Children 5–14 years: Weight (kg) = 4 × age in years 10
Alternative Formula (Also Superior to APLS):
- Children 1–13 years: Weight (kg) = 3 × (age in years) + 7 11
This alternative formula underestimates weight by only 6.9% compared to the APLS formula's 33.4% underestimation and can be used across a broader age range. 11
Critical Caveat About Age-Based Estimation:
Age-based formulas provide only rough estimates and may lead to under-resuscitation in critically ill children if used to calculate drug and fluid dosages. 11 Always obtain actual weight whenever possible, especially for:
- Medications with narrow therapeutic indices (e.g., chemotherapy, anticoagulants, antiarrhythmics) 1, 6
- Drugs primarily metabolized by the liver in children <2 months 6
- Situations requiring precise dosing for safety (e.g., anaphylaxis treatment with epinephrine) 12
Special Dosing Considerations by Age Group
Neonates and Infants <3 Months:
Extreme caution required for hepatically metabolized drugs—use therapeutic drug monitoring and adjust based on clinical response. 6
Oseltamivir: 3 mg/kg/dose twice daily for treatment; chemoprophylaxis not recommended unless situation is critical due to limited safety data. 3, 4, 13
Preterm infants: Require lower weight-based doses than term infants due to immature renal function; use postmenstrual age (PMA) for dosing adjustments. 3
Infants 3–12 Months:
General guideline: Weight-based dosing is appropriate for most medications. 6
Oseltamivir: 3 mg/kg/dose twice daily (infants 3–11 months); 3.5 mg/kg/dose twice daily (infants 9–11 months per some guidelines). 3, 13
Children 1–5 Years:
- Transition period: BSA becomes increasingly relevant after 6 months, but weight-based dosing remains standard for most medications. 6
Children >5 Years and Adolescents:
BSA-based dosing is appropriate for many medications, particularly chemotherapy agents. 6, 14
Practical BSA-equivalent formula: Up to 30 kg, dose = (weight × 2)% of adult dose; over 30 kg, dose = (weight + 30)% of adult dose. 14
Adult dosing begins at age 15 years for many medications. 1, 5
Dose Rounding and Administration
Electronic prescribing systems should incorporate medication-specific rounding tolerances to generate doses that are both safe and practical to measure. 15
Three Categories of Rounding Philosophy:
Medications requiring judicious rounding to retain intended therapeutic effect (e.g., narrow therapeutic index drugs) 15
Medications rounded with attention to potential unintended effects (e.g., most antibiotics, antivirals) 15
Medications rarely rounded due to toxicity potential (e.g., chemotherapy, anticoagulants, antiarrhythmics) 15
Practical Measurement Considerations:
For infants <1 year, use appropriate measuring devices such as 3-mL or 5-mL oral syringes instead of standard dosing cups. 3
Liquid formulations: Round to volumes that can be accurately measured (e.g., 2.5 mL, 5 mL, 7.5 mL increments for oral suspensions). 3, 4
Common Pitfalls to Avoid
Never use outdated APLS formula (Weight = 2[age + 4])—it underestimates by 33% and may lead to underdosing. 11
Do not assume all pediatric medications require weight-based dosing—some are better dosed by age (e.g., intravenous busulfan, dalteparin) or BSA (e.g., certain chemotherapy agents). 16, 6
Avoid using total body weight for ideal-body-weight-based drugs (e.g., atracurium, rocuronium require ideal body weight calculations). 16
Do not forget renal dose adjustments—many medications require dose reduction in renal impairment even in children. 3, 4, 17
Never combine contraindicated medications—for example, metoclopramide must never be combined with tramadol in any pediatric patient. 8